SHAREHOLDER Inform: Pomerantz Law Agency Investigates Promises On Behalf Of Investors Of Silk Road Professional medical, Inc. – Silk
NEW YORK, Feb. 5, 2021
NEW YORK, Feb. 5, 2021 /PRNewswire/ — Pomerantz LLP is investigating statements on behalf of traders of Silk Highway Medical, Inc. (“Silk Street” or the “Business”) (NASDAQ: SILK). Such buyers are suggested to speak to Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
The investigation concerns irrespective of whether Silk Highway and specific of its officers and/or administrators have engaged in securities fraud or other unlawful small business tactics.
On January 13, 2021, Silk Highway announced in a U.S. Securities and Trade Commission filing that the Organization was “voluntarily recalling 288 models of our ENROUTE® Transcarotid Stent System, or ENROUTE SDS, based on 5 studies we gained relevant to the tip of the stent delivery system turning out to be detached in five TCAR strategies. These studies have been produced amongst September 2020 and January 2021 and we have commenced an investigation into this subject.”
On this news, Silk Road’s stock cost fell $4.22 for each share, or 7.12%, to shut at $55.02 per share on January 13, 2021.
The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the leading companies in the locations of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, recognised as the dean of the class action bar, the Pomerantz Company pioneered the discipline of securities course actions. These days, much more than 80 several years later, the Pomerantz Agency carries on in the custom he established, fighting for the legal rights of the victims of securities fraud, breaches of fiduciary responsibility, and company misconduct. The Company has recovered a lot of multimillion-dollar damages awards on behalf of course customers. See www.pomerantzlaw.com.
Get hold of:
Robert S. Willoughby
888-476-6529 ext. 7980
View initial material:http://www.prnewswire.com/information-releases/shareholder-alert-pomerantz-law-business-investigates-statements-on-behalf-of-investors-of-silk-road-professional medical-inc—silk-301222902.html
Source Pomerantz LLP